Diabetes Obes Metab 22(8):13281338
Ludvik B, Giorgino F, Jodar E, Frias JP, Fernandez Lando L, Brown K, et al
None of these platforms is risk-free the boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, and GLP-1 medications carry well-documented GI side effects (nausea, vomiting, diarrhea, constipation) plus less-common documented events including pancreatitis, gallbladder disease, and acute kidney injury
That distinction matters in a category where "copper peptide" is increasingly used as a marketing term rather than as proof of potency
- - 9, 12, - -
Currently, Sermorelin is not FDA-approved for any indication in adults or children